Literature DB >> 23089631

GLP-1 analog attenuates cocaine reward.

D L Graham, K Erreger, A Galli, G D Stanwood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23089631      PMCID： PMC3700649          DOI： 10.1038/mp.2012.141

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN： 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  11 in total

Review 1.  Common cellular and molecular mechanisms in obesity and drug addiction.

Authors:  Paul J Kenny
Journal:  Nat Rev Neurosci       Date:  2011-10-20       Impact factor: 34.870

2.  Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine.

Authors:  W Anthony Owens; Rajkumar J Sevak; Ruggero Galici; Xiaoying Chang; Martin A Javors; Aurelio Galli; Charles P France; Lynette C Daws
Journal:  J Neurochem       Date:  2005-06-30       Impact factor: 5.372

3.  GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake.

Authors:  Amber L Alhadeff; Laura E Rupprecht; Matthew R Hayes
Journal:  Endocrinology       Date:  2011-11-29       Impact factor: 4.736

4.  Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta).

Authors:  A A Young; B R Gedulin; S Bhavsar; N Bodkin; C Jodka; B Hansen; M Denaro
Journal:  Diabetes       Date:  1999-05       Impact factor: 9.461

5.  Exendin-4 decreases amphetamine-induced locomotor activity.

Authors:  Kevin Erreger; Adeola R Davis; Amanda M Poe; Nigel H Greig; Gregg D Stanwood; Aurelio Galli
Journal:  Physiol Behav       Date:  2012-03-19

6.  Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.

Authors:  Scott E Kanoski; Samantha M Fortin; Myrtha Arnold; Harvey J Grill; Matthew R Hayes
Journal:  Endocrinology       Date:  2011-06-21       Impact factor: 4.736

7.  Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake.

Authors:  Amanda M Dossat; Nicole Lilly; Kristen Kay; Diana L Williams
Journal:  J Neurosci       Date:  2011-10-12       Impact factor: 6.167

Review 8.  Neurocircuitry of addiction.

Authors:  George F Koob; Nora D Volkow
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

9.  A library of 7TM receptor C-terminal tails. Interactions with the proposed post-endocytic sorting proteins ERM-binding phosphoprotein 50 (EBP50), N-ethylmaleimide-sensitive factor (NSF), sorting nexin 1 (SNX1), and G protein-coupled receptor-associated sorting protein (GASP).

Authors:  Arne Heydorn; Birgitte P Søndergaard; Bjarne Ersbøll; Birgitte Holst; Finn Cilius Nielsen; Carol Renfrew Haft; Jennifer Whistler; Thue W Schwartz
Journal:  J Biol Chem       Date:  2004-09-27       Impact factor: 5.157

10.  A role for glucagon-like peptide-1 in the central regulation of feeding.

Authors:  M D Turton; D O'Shea; I Gunn; S A Beak; C M Edwards; K Meeran; S J Choi; G M Taylor; M M Heath; P D Lambert; J P Wilding; D M Smith; M A Ghatei; J Herbert; S R Bloom
Journal:  Nature       Date:  1996-01-04       Impact factor: 49.962
View more
  53 in total

Review 1.  Central GLP-1 receptors: Novel molecular targets for cocaine use disorder.

Authors:  N S Hernandez; H D Schmidt
Journal:  Physiol Behav       Date:  2019-03-28

2.  Septal Glucagon-Like Peptide 1 Receptor Expression Determines Suppression of Cocaine-Induced Behavior.

Authors:  Anne E Harasta; John M Power; Georg von Jonquieres; Tim Karl; Daniel J Drucker; Gary D Housley; Miriam Schneider; Matthias Klugmann
Journal:  Neuropsychopharmacology       Date:  2015-02-11       Impact factor: 7.853

3.  Central GLP-1 receptor activation modulates cocaine-evoked phasic dopamine signaling in the nucleus accumbens core.

Authors:  Samantha M Fortin; Mitchell F Roitman
Journal:  Physiol Behav       Date:  2017-03-16

Review 4.  Examining weight suppression as a transdiagnostic factor influencing illness trajectory in bulimic eating disorders.

Authors:  Pamela K Keel; Lindsay P Bodell; K Jean Forney; Jonathan Appelbaum; Diana Williams
Journal:  Physiol Behav       Date:  2019-05-30

Review 5.  The effect of glucagon-like peptide-1 (GLP-1) receptor agonists on substance use disorder (SUD)-related behavioural effects of drugs and alcohol: A systematic review.

Authors:  Amanda Brunchmann; Morgane Thomsen; Anders Fink-Jensen
Journal:  Physiol Behav       Date:  2019-04-01

Review 6.  PPG neurons of the lower brain stem and their role in brain GLP-1 receptor activation.

Authors:  Stefan Trapp; Simon C Cork
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-08-19       Impact factor: 3.619

7.  Activation of glucagon-like peptide-1 receptors in the nucleus accumbens attenuates cocaine seeking in rats.

Authors:  Nicole S Hernandez; Bernadette O'Donovan; Pavel I Ortinski; Heath D Schmidt
Journal:  Addict Biol       Date:  2017-12-11       Impact factor: 4.280

8.  The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice.

Authors:  Gunnar Sørensen; India A Reddy; Pia Weikop; Devon L Graham; Gregg D Stanwood; Gitta Wortwein; Aurelio Galli; Anders Fink-Jensen
Journal:  Physiol Behav       Date:  2015-06-11

9.  Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose.

Authors:  Matthew R Hayes; Elizabeth G Mietlicki-Baase; Scott E Kanoski; Bart C De Jonghe
Journal:  Annu Rev Nutr       Date:  2014-04-10       Impact factor: 11.848

10.  Effects of the GLP-1 Agonist Exendin-4 on Intravenous Ethanol Self-Administration in Mice.

Authors:  Gunnar Sørensen; S Barak Caine; Morgane Thomsen
Journal:  Alcohol Clin Exp Res       Date:  2016-08-31       Impact factor: 3.455
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.